Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

Recruiting now

Conditions studied: Aortic Aneurysm, Aortic Dissection, Aortic Diseases

In brief

The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.

Key facts

Study ID
NCT04005976
Run by
The University of Texas Health Science Center, Houston
People needed
5000
Starts
2016-06-15
Expected to finish
2037-01-01
Last updated by the study team
2026-02-02

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.